A fast screening software that can be used for all age groups.
It returns a simple pass/refer result, requires minimal tester training and is automatic and objective. ABRIS specificity (the ability to correctly exclude normal hearing babies) is as high as 99.7% in large scale clinical trials using two stage screening.
ABRIS sensitivity (the ability to correctly identify babies with hearing problems) is 99.99% based on large-scale simulations.
Click edit button to change this text.